Results 191 to 200 of about 39,875 (271)

Symposia

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Optical coherence tomography findings in Duchenne muscular dystrophy. [PDF]

BMC Ophthalmol
Yöyler G, Adıyeke SK.
europepmc   +1 more source

State-of-the-Art Research and New Pharmacological Perspectives on Renal Involvement in Duchenne Muscular Dystrophy: A Narrative Review. [PDF]

Biomedicines
Bellis M, Imbrici P, Lenti R, Liantonio A, De Luca A.   +4 more
europepmc   +1 more source

Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection. [PDF]

Muscles
Pesco MT, Öztürk GZ, Bhadola SC, Chrzanowski SM, Gushchina LV, D'Ambrosio ES.   +5 more
europepmc   +1 more source

Age-related progression of myocardial dysfunction in patients with Duchenne muscular dystrophy assessed by cardiac magnetic resonance tissue tracking: a case-control study. [PDF]

Cardiovasc Diagn Ther
Liu H, Xu HY, Xu R, Fu H, Guo YK, Gong LG.   +5 more
europepmc   +1 more source

Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain. [PDF]

Neurol Ther
Ortez C, Branas-Pampillón M, Fernandez JA, Guillen E, Terrancle Á, Maurino J, Montolio M, Camacho A.   +7 more
europepmc   +1 more source

Neonatal screening for Duchenne muscular dystrophy in eastern China: a closed prospective study. [PDF]

Transl Pediatr
Qian G, Yang R, Huang X, Wu D, Fang K, Zhao Z.   +5 more
europepmc   +1 more source

The miR-30c-5p/SOCS3 axis is a potential driver of inflammation and metabolic imbalance in Duchenne muscular dystrophy. [PDF]

Front Cell Dev Biol
Wang Y, Ai X, Chang Y, Zhang S, Zhang P, Wu S.   +5 more
europepmc   +1 more source